Skip to content

Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)

Subdural Hematoma

EMMA-Can is a prospective cohort study to assess the safety and effectiveness of MMA-embolization for the treatment of CSDH.

Hypothesis- EMMA reduces the recurrence rate of SDH with or without concomitant surgical evacuation.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* All patients with subdural hematoma coming to the emergency room or to neurosurgical outpatient clinic

Exclusion Criteria:

* When informed consent is not possible
* Known allergy to liquid embolic agent

Lieu de l'étude

Health Sciences centre
Health Sciences centre
Winnipeg MB, Manitoba
Canada

Contactez l'équipe d'étude

Primary Contact

Jai Shankar, MD FRCPC

[email protected]
431 373 4164
Backup Contact

Susan Alcock

[email protected]
204 789 3996
Étude parrainée par
University of Manitoba
Participants recherchés
Plus d'informations
ID de l'étude: NCT04923984